The thymocyte-specific RNA-binding protein Arpp21 provides TCR repertoire diversity by binding to the 3'-UTR and promoting Rag1 mRNA expression.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
11 Mar 2024
Historique:
received: 20 04 2023
accepted: 26 02 2024
medline: 12 3 2024
pubmed: 12 3 2024
entrez: 12 3 2024
Statut: epublish

Résumé

The regulation of thymocyte development by RNA-binding proteins (RBPs) is largely unexplored. We identify 642 RBPs in the thymus and focus on Arpp21, which shows selective and dynamic expression in early thymocytes. Arpp21 is downregulated in response to T cell receptor (TCR) and Ca

Identifiants

pubmed: 38467629
doi: 10.1038/s41467-024-46371-z
pii: 10.1038/s41467-024-46371-z
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2194

Subventions

Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : SFB 1054 # 210592381

Informations de copyright

© 2024. The Author(s).

Références

Behrens, G. et al. Disrupting Roquin-1 interaction with Regnase-1 induces autoimmunity and enhances antitumor responses. Nat. Immunol. 22, 1563–1576 (2021).
pubmed: 34811541 pmcid: 8996344 doi: 10.1038/s41590-021-01064-3
Jeltsch, K. M. et al. Cleavage of roquin and regnase-1 by the paracaspase MALT1 releases their cooperatively repressed targets to promote T(H)17 differentiation. Nat. Immunol. 15, 1079–1089 (2014).
pubmed: 25282160 doi: 10.1038/ni.3008
Matsushita, K. et al. Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay. Nature 458, 1185–1190 (2009).
pubmed: 19322177 doi: 10.1038/nature07924
Tavernier, S. J. et al. A human immune dysregulation syndrome characterized by severe hyperinflammation with a homozygous nonsense Roquin-1 mutation. Nat. Commun. 10, 4779 (2019).
pubmed: 31636267 pmcid: 6803705 doi: 10.1038/s41467-019-12704-6
Taylor, G. A. et al. A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 4, 445–454 (1996).
pubmed: 8630730 doi: 10.1016/S1074-7613(00)80411-2
Vinuesa, C. G. et al. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 435, 452–458 (2005).
pubmed: 15917799 doi: 10.1038/nature03555
Vogel, K. U. et al. Roquin paralogs 1 and 2 redundantly repress the Icos and Ox40 costimulator mRNAs and control follicular helper T cell differentiation. Immunity 38, 655–668 (2013).
pubmed: 23583643 doi: 10.1016/j.immuni.2012.12.004
Krueger, A., Lyszkiewicz, M. & Heissmeyer, V. Post-transcriptional control of T-cell development in the thymus. Immunol. Lett. 247, 1–12 (2022).
pubmed: 35609352 doi: 10.1016/j.imlet.2022.04.009
Kim, M. S., Lapkouski, M., Yang, W. & Gellert, M. Crystal structure of the V(D)J recombinase RAG1-RAG2. Nature 518, 507–511 (2015).
pubmed: 25707801 pmcid: 4342785 doi: 10.1038/nature14174
Engel, I. & Murre, C. E2A proteins enforce a proliferation checkpoint in developing thymocytes. EMBO J. 23, 202–211 (2004).
pubmed: 14685278 doi: 10.1038/sj.emboj.7600017
Wilson, A., Held, W. & MacDonald, H. R. Two waves of recombinase gene expression in developing thymocytes. J. Exp. Med. 179, 1355–1360 (1994).
pubmed: 8145048 doi: 10.1084/jem.179.4.1355
Rothenberg, E. V. Programming for T-lymphocyte fates: modularity and mechanisms. Genes Dev. 33, 1117–1135 (2019).
pubmed: 31481536 pmcid: 6719619 doi: 10.1101/gad.327163.119
Delmonte, O. M., Villa, A. & Notarangelo, L. D. Immune dysregulation in patients with RAG deficiency and other forms of combined immune deficiency. Blood 135, 610–619 (2020).
pubmed: 31942628 pmcid: 7046604 doi: 10.1182/blood.2019000923
Rehfeld, F. et al. The RNA-binding protein ARPP21 controls dendritic branching by functionally opposing the miRNA it hosts. Nat. Commun. 9, 1235 (2018).
pubmed: 29581509 pmcid: 5964322 doi: 10.1038/s41467-018-03681-3
Rakhilin, S. V. et al. A network of control mediated by regulator of calcium/calmodulin-dependent signaling. Science 306, 698–701 (2004).
pubmed: 15499021 doi: 10.1126/science.1099961
Kisielow, J., Nairn, A. C. & Karjalainen, K. TARPP, a novel protein that accompanies TCR gene rearrangement and thymocyte education. Eur. J. Immunol. 31, 1141–1149 (2001).
pubmed: 11298339 doi: 10.1002/1521-4141(200104)31:4<1141::AID-IMMU1141>3.0.CO;2-R
Queiroz, R. M. L. et al. Comprehensive identification of RNA-protein interactions in any organism using orthogonal organic phase separation (OOPS). Nat. Biotechnol. 37, 169–178 (2019).
pubmed: 30607034 pmcid: 6591131 doi: 10.1038/s41587-018-0001-2
Liao, J. Y. et al. EuRBPDB: a comprehensive resource for annotation, functional and oncological investigation of eukaryotic RNA binding proteins (RBPs). Nucleic Acids Res. 48, D307–D313 (2020).
pubmed: 31598693 doi: 10.1093/nar/gkz823
Kramer, K. et al. Photo-cross-linking and high-resolution mass spectrometry for assignment of RNA-binding sites in RNA-binding proteins. Nat. Methods 11, 1064–1070 (2014).
pubmed: 25173706 pmcid: 6485471 doi: 10.1038/nmeth.3092
Hoefig, K. P. et al. Defining the RBPome of primary T helper cells to elucidate higher-order Roquin-mediated mRNA regulation. Nat. Commun. 12, 5208 (2021).
pubmed: 34471108 pmcid: 8410761 doi: 10.1038/s41467-021-25345-5
Mingueneau, M. et al. The transcriptional landscape of alphabeta T cell differentiation. Nat. Immunol. 14, 619–632 (2013).
pubmed: 23644507 pmcid: 3660436 doi: 10.1038/ni.2590
Fu, G. et al. Fine-tuning T cell receptor signaling to control T cell development. Trends Immunol. 35, 311–318 (2014).
pubmed: 24951034 pmcid: 4119814 doi: 10.1016/j.it.2014.05.003
Zhang, X. et al. Distinct pharmacological profiles of ORAI1, ORAI2, and ORAI3 channels. Cell Calcium 91, 102281 (2020).
pubmed: 32896813 pmcid: 7654283 doi: 10.1016/j.ceca.2020.102281
Otomo, K. et al. Cutting edge: nanogel-based delivery of an inhibitor of CaMK4 to CD4+ T cells suppresses experimental autoimmune encephalomyelitis and lupus-like disease in mice. J. Immunol. 195, 5533–5537 (2015).
pubmed: 26561550 doi: 10.4049/jimmunol.1501603
Chen, C. Z., Li, L., Lodish, H. F. & Bartel, D. P. MicroRNAs modulate hematopoietic lineage differentiation. Science 303, 83–86 (2004).
pubmed: 14657504 doi: 10.1126/science.1091903
Grewers, Z. & Krueger, A. MicroRNA miR-181-A rheostat for TCR signaling in thymic selection and peripheral T-cell function. Int J. Mol. Sci. 21, 6200 (2020).
pubmed: 32867301 pmcid: 7503384 doi: 10.3390/ijms21176200
Krakau, S., Richard, H. & Marsico, A. PureCLIP: capturing target-specific protein-RNA interaction footprints from single-nucleotide CLIP-seq data. Genome Biol. 18, 240 (2017).
pubmed: 29284540 pmcid: 5746957 doi: 10.1186/s13059-017-1364-2
Dudley, E. C., Petrie, H. T., Shah, L. M., Owen, M. J. & Hayday, A. C. T cell receptor beta chain gene rearrangement and selection during thymocyte development in adult mice. Immunity 1, 83–93 (1994).
pubmed: 7534200 doi: 10.1016/1074-7613(94)90102-3
Tsuda, S., Rieke, S., Hashimoto, Y., Nakauchi, H. & Takahama, Y. Il-7 supports D-J but not V-DJ rearrangement of TCR-beta gene in fetal liver progenitor cells. J. Immunol. 156, 3233–3242 (1996).
pubmed: 8617945 doi: 10.4049/jimmunol.156.9.3233
Abarrategui, I. & Krangel, M. S. Regulation of T cell receptor-alpha gene recombination by transcription. Nat. Immunol. 7, 1109–1115 (2006).
pubmed: 16936730 doi: 10.1038/ni1379
Guo, J. et al. Regulation of the TCRalpha repertoire by the survival window of CD4(+)CD8(+) thymocytes. Nat. Immunol. 3, 469–476 (2002).
pubmed: 11967541 doi: 10.1038/ni791
Hawwari, A., Bock, C. & Krangel, M. S. Regulation of T cell receptor alpha gene assembly by a complex hierarchy of germline Jalpha promoters. Nat. Immunol. 6, 481–489 (2005).
pubmed: 15806105 pmcid: 2413064 doi: 10.1038/ni1189
McInnes, L., Healy, J. & Melville, J. UMAP: uniform manifold approximation and projection for dimension reduction. https://doi.org/10.48550/arXiv.1802.03426 .
Kuo, T. C. & Schlissel, M. S. Mechanisms controlling expression of the RAG locus during lymphocyte development. Curr. Opin. Immunol. 21, 173–178 (2009).
pubmed: 19359154 pmcid: 2676217 doi: 10.1016/j.coi.2009.03.008
Miyazaki, K. et al. The transcription factor E2A activates multiple enhancers that drive Rag expression in developing T and B cells. Sci. Immunol. 5, eabb1455 (2020).
pubmed: 32887843 doi: 10.1126/sciimmunol.abb1455
Miyazaki, M. et al. The E-Id protein axis specifies adaptive lymphoid cell identity and suppresses thymic innate lymphoid cell development. Immunity 46, 818–834.e814 (2017).
pubmed: 28514688 pmcid: 5512722 doi: 10.1016/j.immuni.2017.04.022
Wang, X. & Rothenberg, E. V. Illuminating the core of adaptive immunity-how the regulatory genome controls Rag chromatin dynamics. Sci. Immunol. 5, eabd6427 (2020).
pubmed: 32887844 doi: 10.1126/sciimmunol.abd6427
Neale, G. A., Fitzgerald, T. J. & Goorha, R. M. Expression of the V(D)J recombinase gene RAG-1 is tightly regulated and involves both transcriptional and post-transcriptional controls. Mol. Immunol. 29, 1457–1466 (1992).
pubmed: 1454064 doi: 10.1016/0161-5890(92)90219-N
Schabla, N. M., Perry, G. A., Palmer, V. L. & Swanson, P. C. VprBP (DCAF1) regulates RAG1 expression independently of dicer by mediating RAG1 degradation. J. Immunol. 201, 930–939 (2018).
pubmed: 29925675 doi: 10.4049/jimmunol.1800054
Schabla, N. M. & Swanson, P. C. The CRL4VPRBP(DCAF1) E3 ubiquitin ligase directs constitutive RAG1 degradation in a non-lymphoid cell line. PLoS One 16, e0258683 (2021).
pubmed: 34648572 pmcid: 8516306 doi: 10.1371/journal.pone.0258683
Jiang, H. et al. Ubiquitylation of RAG-2 by Skp2-SCF links destruction of the V(D)J recombinase to the cell cycle. Mol. Cell 18, 699–709 (2005).
pubmed: 15949444 doi: 10.1016/j.molcel.2005.05.011
Li, Z., Dordai, D. I., Lee, J. & Desiderio, S. A conserved degradation signal regulates RAG-2 accumulation during cell division and links V(D)J recombination to the cell cycle. Immunity 5, 575–589 (1996).
pubmed: 8986717 doi: 10.1016/S1074-7613(00)80272-1
Chen, C. C. et al. Sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) activity is required for V(D)J recombination. J. Exp. Med. 218, e20201708 (2021).
pubmed: 34033676 pmcid: 8155808 doi: 10.1084/jem.20201708
Ouyang, K. et al. Loss of IP3R-dependent Ca2+ signalling in thymocytes leads to aberrant development and acute lymphoblastic leukemia. Nat. Commun. 5, 4814 (2014).
pubmed: 25215520 doi: 10.1038/ncomms5814
Tan, C. L. et al. MicroRNA-128 governs neuronal excitability and motor behavior in mice. Science 342, 1254–1258 (2013).
pubmed: 24311694 pmcid: 3932786 doi: 10.1126/science.1244193
Marrella, V. et al. A hypomorphic R229Q Rag2 mouse mutant recapitulates human Omenn syndrome. J. Clin. Investig. 117, 1260–1269 (2007).
pubmed: 17476358 pmcid: 1857243 doi: 10.1172/JCI30928
Brooks, E. G., Filipovich, A. H., Padgett, J. W., Mamlock, R. & Goldblum, R. M. T-cell receptor analysis in Omenn’s syndrome: evidence for defects in gene rearrangement and assembly. Blood 93, 242–250 (1999).
pubmed: 9864167 doi: 10.1182/blood.V93.1.242
Oh-Hora, M. et al. Agonist-selected T cell development requires strong T cell receptor signaling and store-operated calcium entry. Immunity 38, 881–895 (2013).
pubmed: 23499491 pmcid: 3669219 doi: 10.1016/j.immuni.2013.02.008
Oh-Hora, M. et al. Dual functions for the endoplasmic reticulum calcium sensors STIM1 and STIM2 in T cell activation and tolerance. Nat. Immunol. 9, 432–443 (2008).
pubmed: 18327260 pmcid: 2737533 doi: 10.1038/ni1574
Hughes, C. S. et al. Single-pot, solid-phase-enhanced sample preparation for proteomics experiments. Nat. Protoc. 14, 68–85 (2019).
pubmed: 30464214 doi: 10.1038/s41596-018-0082-x
Delaglio, F. et al. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6, 277–293 (1995).
pubmed: 8520220 doi: 10.1007/BF00197809
Blomberg, N., Sattler, M. & Nilges, M. 1H, 15N, and 13C resonance assignment of the PH domain from C. elegans UNC-89. J. Biomol. NMR 15, 269–270 (1999).
pubmed: 10677831 doi: 10.1023/A:1008322528413
Hoefig, K. P. & Heissmeyer, V. Measuring microRNA expression in size-limited FACS-sorted and microdissected samples. Methods Mol. Biol. 667, 47–63 (2010).
pubmed: 20827526 doi: 10.1007/978-1-60761-811-9_4
Bolotin, D. A. et al. MiXCR: software for comprehensive adaptive immunity profiling. Nat. Methods 12, 380–381 (2015).
pubmed: 25924071 doi: 10.1038/nmeth.3364
Shugay, M. et al. VDJtools: Unifying Post-analysis of T Cell Receptor Repertoires. PLoS Comput. Biol. 11, e1004503 (2015).
pubmed: 26606115 pmcid: 4659587 doi: 10.1371/journal.pcbi.1004503
Buchbender, A. et al. Improved library preparation with the new iCLIP2 protocol. Methods 178, 33–48 (2020).
pubmed: 31610236 doi: 10.1016/j.ymeth.2019.10.003
Bosc, N. & Lefranc, M. P. The mouse (Mus musculus) T cell receptor alpha (TRA) and delta (TRD) variable genes. Dev. Comp. Immunol. 27, 465–497 (2003).
pubmed: 12697305 doi: 10.1016/S0145-305X(03)00027-2

Auteurs

Meng Xu (M)

Research Unit Molecular Immune Regulation, Molecular Targets and Therapeutics Center, Helmholtz Zentrum München, Munich, Germany.
Department of Integrated Traditional Chinese and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Taku Ito-Kureha (T)

Institute for Immunology, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-Universität in Munich, Planegg-Martinsried, Germany.

Hyun-Seo Kang (HS)

Institute of Structural Biology, Molecular Targets and Therapeutics Center, Helmholtz Zentrum München, Neuherberg, Germany.
Technical University of Munich, TUM School of Natural Sciences, Department of Bioscience and Bavarian NMR Center (BNMRZ), Garching, Germany.

Aleksandar Chernev (A)

Max Planck Institute for Multidisciplinary Sciences, Bioanalytical Mass Spectrometry, Göttingen, Germany.

Timsse Raj (T)

Institute for Immunology, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-Universität in Munich, Planegg-Martinsried, Germany.

Kai P Hoefig (KP)

Research Unit Molecular Immune Regulation, Molecular Targets and Therapeutics Center, Helmholtz Zentrum München, Munich, Germany.

Christine Hohn (C)

Institute for Immunology, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-Universität in Munich, Planegg-Martinsried, Germany.

Florian Giesert (F)

Institute of Developmental Genetics, Helmholtz Zentrum München, Neuherberg, Germany.

Yinhu Wang (Y)

Department of Pathology, New York University, Grossman School of Medicine, New York, NY, USA.

Wenliang Pan (W)

Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Natalia Ziętara (N)

Institute for Immunology, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-Universität in Munich, Planegg-Martinsried, Germany.
Cancer Immunology and Immune Modulation, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.

Tobias Straub (T)

Institute for Molecular Biology, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-Universität in Munich, Planegg-Martinsried, Germany.

Regina Feederle (R)

Monoclonal Antibody Core Facility, German Research Center for Environmental Health, Neuherberg, Germany.

Carolin Daniel (C)

Research Unit Type 1 Diabetes Immunology, Helmholtz Diabetes Center at Helmholtz Zentrum München, Neuherberg, Germany.
German Center for Diabetes Research (DZD), Neuherberg, Germany.
Division of Clinical Pharmacology, Department of Medicine IV, Ludwig-Maximilians-Universität München, Munich, Germany.

Barbara Adler (B)

Max von Pettenkofer Institute, Faculty of Medicine, Ludwig-Maximilians-Universität in Munich, Munich, Germany.

Julian König (J)

Institute of Molecular Biology (IMB), Mainz, Germany.

Stefan Feske (S)

Department of Pathology, New York University, Grossman School of Medicine, New York, NY, USA.

George C Tsokos (GC)

Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Wolfgang Wurst (W)

Institute of Developmental Genetics, Helmholtz Zentrum München, Neuherberg, Germany.
Chair of Developmental Genetics, Munich School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany.
Munich Cluster of Systems Neurology (SyNergy), Munich, Germany.
German Center for Neurodegenerative Diseases (DZNE) site Munich, Munich, Germany.

Henning Urlaub (H)

Max Planck Institute for Multidisciplinary Sciences, Bioanalytical Mass Spectrometry, Göttingen, Germany.
University Medical Center Göttingen, Department of Clinical Chemistry, Bioanalytics Group, Göttingen, Germany.
Göttingen Center for Molecular Biosciences, Georg-August University Göttingen, Göttingen, Germany.
Cluster of Excellence 'Multiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells' (MBExC), University of Göttingen, Göttingen, Germany.

Michael Sattler (M)

Institute of Structural Biology, Molecular Targets and Therapeutics Center, Helmholtz Zentrum München, Neuherberg, Germany.
Technical University of Munich, TUM School of Natural Sciences, Department of Bioscience and Bavarian NMR Center (BNMRZ), Garching, Germany.

Jan Kisielow (J)

Institute for Molecular Health Sciences, ETH Zürich, Zürich, Switzerland. jk@repertoire.com.
Repertoire Immune Medicines (Switzerland) AG, Schlieren, Switzerland. jk@repertoire.com.

F Gregory Wulczyn (FG)

Institute for Integrative Neuroanatomie, Charite-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. gregory.wulczyn@charite.de.

Marcin Łyszkiewicz (M)

Research Unit Molecular Immune Regulation, Molecular Targets and Therapeutics Center, Helmholtz Zentrum München, Munich, Germany. marcin.lyszkiewicz@uni-ulm.de.
Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany. marcin.lyszkiewicz@uni-ulm.de.

Vigo Heissmeyer (V)

Research Unit Molecular Immune Regulation, Molecular Targets and Therapeutics Center, Helmholtz Zentrum München, Munich, Germany. vigo.heissmeyer@med.uni-muenchen.de.
Institute for Immunology, Biomedical Center (BMC), Faculty of Medicine, Ludwig-Maximilians-Universität in Munich, Planegg-Martinsried, Germany. vigo.heissmeyer@med.uni-muenchen.de.

Classifications MeSH